# Agents
18 Apr
Decarbonization in 2026: From Climate Ambition to Industrial Reality
Introduction Decarbonization has moved beyond policy ambition and sustainability pledges—it is now a defining force shaping global competitiveness, capital allocation, and innovation strategies. In 2026, organizations are no longer asking whether to decarbonize, but how fast they can transition while maintaining profitability and resilience. Governments, investors, and consumers are aligning around one expectation: measurable, transparent […]
17 Apr
2026: The Year AI Decides Beauty’s Winners and Losers
The beauty industry has always been driven by innovation—but 2026 marks a structural shift. Artificial Intelligence (AI) is no longer an experimental add-on; it is rapidly becoming the core differentiator between market leaders and laggards. From AI-driven formulation to hyper-personalized skincare recommendations, the brands that embed intelligence into their value chain are setting new benchmarks […]
17 Apr
Biocon’s U.S. Denosumab Biosimilars Launch: A Strategic Inflection Point for the Bone Health Market
On April 7, 2026, Biocon marked a significant milestone with the U.S. commercial launch of Bosaya™ and Aukelso™, its interchangeable denosumab biosimilars referencing blockbuster biologics Prolia and Xgeva. This development is more than a product launch—it signals a deeper transformation underway in high-value therapeutic segments such as bone health, oncology, and immunology, where biosimilars are […]
17 Apr
GLP-1 Medications Are Reshaping the Food Industry: A Strategic Imperative for F&B Companies
The European Union is entering a decisive phase in its sustainability journey with the implementation of the Packaging and Packaging Waste Regulation (PPWR). Effective August 12, 2026, the regulation introduces stringent restrictions on per- and polyfluoroalkyl substances (PFAS) in food-contact packaging—without any transition window for newly placed products. This is not just another regulatory update. […]
16 Apr
EU Packaging Regulation (PPWR): How PFAS Restrictions Will Redefine Packaging Compliance by 2026
The European Union is entering a decisive phase in its sustainability journey with the implementation of the Packaging and Packaging Waste Regulation (PPWR). Effective August 12, 2026, the regulation introduces stringent restrictions on per- and polyfluoroalkyl substances (PFAS) in food-contact packaging—without any transition window for newly placed products. This is not just another regulatory update. […]
16 Apr
The EIA raised its 2026 Brent crude oil price forecast to $96 per barrel following Strait of Hormuz disruptions
Introduction: A Market Under Pressure The global oil market has once again entered a phase of heightened uncertainty. The latest upward revision in Brent crude oil price forecasts for 2026 reflects not just a temporary supply disruption, but a deeper structural vulnerability in global energy logistics. With Brent averaging above expectations and projected to peak […]
15 Apr
Fertilizer prices to remain elevated through 2027 due to ongoing global supply tightness linked to energy market volatility and Hormuz disruptions
Introduction Global fertilizer markets are entering a prolonged period of price elevation, with forecasts suggesting sustained high costs through 2027. The primary drivers—energy market volatility and geopolitical disruptions such as those impacting the Strait of Hormuz—are tightening supply chains and increasing production costs, particularly for nitrogen-based fertilizers. For industries dependent on agricultural inputs, this is […]
15 Apr
Strait of Hormuz tensions in 2026 continue to create supply risks for generic drugs reaching the U.S. market.
Introduction The escalating tensions in the Strait of Hormuz in 2026 have evolved from an energy crisis into a critical healthcare supply chain risk. What began as geopolitical friction has now exposed structural vulnerabilities in the global pharmaceutical ecosystem—particularly impacting the flow of generic drugs to the United States. With India supplying a significant share […]
14 Apr
Eli Lilly just committed up to $2.75 billion to AI-designed drugs through its new deal with Insilico Medicine
The pharmaceutical industry is entering a new era—one where algorithms, not just laboratories, play a central role in discovering life-saving therapies. This shift was underscored by Eli Lilly’s recent commitment of up to $2.75 billion in a strategic partnership with Insilico Medicine, announced on March 29, 2026. The deal includes an upfront payment of $115 […]
14 Apr
Amorepacific has created an AI-engineered peptide (Tripeptide-132) designed to strengthen hair keratin
The beauty and personal care industry is entering a new era—one where science, data, and artificial intelligence (AI) converge to redefine how products are developed, tested, and commercialized. A compelling example of this shift is the recent innovation by Amorepacific, which has introduced an AI-engineered peptide, Tripeptide-132, designed to strengthen hair keratin and improve hair […]